KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Net Cash Flow (2017 - 2026)

Twist Bioscience has reported Net Cash Flow over the past 10 years, most recently at -$26.1 million for Q1 2026.

  • Quarterly Net Cash Flow fell 132.94% to -$26.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$88.2 million through Mar 2026, down 164.08% year-over-year, with the annual reading at -$43.8 million for FY2025, 27.25% up from the prior year.
  • Net Cash Flow was -$26.1 million for Q1 2026 at Twist Bioscience, up from -$34.4 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $216.0 million in Q1 2022 and troughed at -$61.4 million in Q4 2022.
  • The 5-year median for Net Cash Flow is -$13.0 million (2024), against an average of -$4.0 million.
  • Year-over-year, Net Cash Flow soared 327.75% in 2022 and then tumbled 1324.52% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at -$61.4 million in 2022, then soared by 66.99% to -$20.3 million in 2023, then surged by 75.25% to -$5.0 million in 2024, then crashed by 586.24% to -$34.4 million in 2025, then increased by 24.16% to -$26.1 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Net Cash Flow are -$26.1 million (Q1 2026), -$34.4 million (Q4 2025), and -$18.6 million (Q3 2025).